The Role of Vitamin D During Therapy in Chronic Hepatitis C Virus Infection and Its Relation to CYP 27 B1-1260 Promoter Polymorphism

2016 ◽  
Vol 64 ◽  
pp. 287-303
Author(s):  
Saadia Farid ◽  
Laila Rashed ◽  
Samya Sweilam
Hepatology ◽  
2000 ◽  
Vol 31 (4) ◽  
pp. 997-1004 ◽  
Author(s):  
Lucia De Franceschi ◽  
Giovanna Fattovich ◽  
Franco Turrini ◽  
Kodjo Ayi ◽  
Carlo Brugnara ◽  
...  

2020 ◽  
Vol 4 (1) ◽  
pp. 1-4
Author(s):  
Hsuan-Wei Chen ◽  
Hsuan-Hwai Lin ◽  
Yu-Lueng Shih ◽  
Tsai-Yuan Hsieh ◽  
Jung-Chun Lin ◽  
...  

2011 ◽  
Vol 140 (5) ◽  
pp. S-934
Author(s):  
Fasiha Kanwal ◽  
Tuyen Hoang ◽  
Jennifer R. Kramer ◽  
Timothy Chrusciel ◽  
Steven M. Asch ◽  
...  

2004 ◽  
Vol 78 (4) ◽  
pp. 2152-2157 ◽  
Author(s):  
Christel Gremion ◽  
Benno Grabscheid ◽  
Benno Wölk ◽  
Darius Moradpour ◽  
Jürg Reichen ◽  
...  

ABSTRACT The role of Fas-mediated lysis of hepatocytes in hepatitis C virus (HCV)-induced injury is frequently discussed. We therefore analyzed the effect of the number of HCV antigen-expressing cells, the mode of antigen presentation, and the number of cytotoxic T lymphocytes in a coculture system mimicking cellular components of the liver. Here, we show that endogenously processed HCV proteins are capable of inducing bystander killing. We further demonstrate that 0.8 to 1.5% of cells presenting HCV antigens suffice to induce lysis of 10 to 29% of bystander cells, suggesting that the mechanism may be operative at low fractions of infected versus uninfected hepatocytes in vivo. Our data underscore the role of the Fas pathway in HCV-related liver injury and support the exploration of Fas-based treatment strategies for patients with chronic hepatitis C virus infection.


2008 ◽  
Vol 14 (47) ◽  
pp. 7149 ◽  
Author(s):  
Juan R Larrubia ◽  
Selma Benito-Martínez ◽  
Miryam Calvino ◽  
Eduardo Sanz-de-Villalobos ◽  
Trinidad Parra-Cid

Sign in / Sign up

Export Citation Format

Share Document